USE OF BASAL INSULIN-GLP1 COMBINATION FOR THERAPEUTIC SIMPLIFICATION IN TYPE 2 DIABETIC PATIENTS WITH A BASAL-BOLUS OR BASAL PLUS SCHEME

被引：0
|
作者：
Jaramillo-Nieto, A. [1 ]
Gomez Hernandez, I. [1 ]
Tique, C. [1 ]
机构：
[1] Fdn Santa Fe Bogota, Endocrinol, Bogota, Colombia
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP237 / #4
引用
收藏
页码：A180 / A180
页数：1
相关论文
共 50 条
  • [21] Comment on basal insulin plus bolus insulin or better plus GLP1-RA?
    Ritzel, Robert A.
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (01) : 30 - 31
  • [22] Comparison of dinner with bedtime administration of insulin glargine in type 1 diabetic patients treated with basal-bolus regimen
    Grimaldi, A.
    Vialettes, B.
    Blayo, A.
    Brun, J. M.
    Halimi, S.
    DIABETES & METABOLISM, 2007, 33 (02) : 121 - 128
  • [23] Experience with Insulin-Bolus Calculator in Diabetes Type 1 Patients in Treatment on Basal-Bolus Regimen
    Tejera, Cristina
    Miguel Morales, Francisco
    Maria Lopez, Ana
    Galvan, Beatriz
    Delgado, Esther
    Beato, Pilar
    Hernandez, Virginia
    DIABETES, 2014, 63 : A596 - A596
  • [24] Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
    Bellido, Virginia
    Suarez, Lorena
    Galiana Rodriguez, Maria
    Sanchez, Cecilia
    Dieguez, Marta
    Riestra, Maria
    Casal, Florentino
    Delgado, Elias
    Menendez, Edelmiro
    Umpierrez, Guillermo E.
    DIABETES CARE, 2015, 38 (12) : 2211 - 2216
  • [25] Comparison of the soluble basal insulin analog insulin detemir with NPH insulin - A randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy
    Hermansen, K
    Madsbad, S
    Perrild, H
    Kristensen, A
    Axelsen, M
    DIABETES CARE, 2001, 24 (02) : 296 - 301
  • [26] Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine care
    Bonora, Benedetta Maria
    Rigato, Mauro
    Frison, Vera
    D'Ambrosio, Michele
    Tadiotto, Federica
    Lapolla, Annunziata
    Simioni, Natalino
    Paccagnella, Agostino
    Avogaro, Angelo
    Fadini, Gian Paolo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 173
  • [27] THE COSTS OF INTENSIFYING TYPE 2 DIABETES PATIENTS TREATED WITH BASAL INSULIN TO BASAL IN COMBINATION WITH GLP-1: A PHYSICIAN SURVEY
    Pfeiffer, K. M.
    Basse, A.
    Brod, M.
    VALUE IN HEALTH, 2018, 21 : S74 - S74
  • [28] Use of Basal-Bolus Subcutaneous Insulin in the Initial Management of Mild to Moderate Diabetic Ketoacidosis is Safe in Type 1 Diabetes
    Meder, Michelle
    Jelley, Hannah
    Mistry, Sejal
    Murray, Mary
    Smego, Allison
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 1): : 76 - 77
  • [29] IMPACT OF PRANDIAL PLUS BASAL VS BASAL INSULIN ON GLYCEMIC VARIABILITY IN TYPE 2 DIABETIC PATIENTS
    Hirsch, Irl B.
    Yuan, Hongbo
    Campaigne, Barbara N.
    Tan, Meng H.
    ENDOCRINE PRACTICE, 2009, 15 (04) : 343 - 348
  • [30] Clinical Impact of GLP-1 receptor agonists in veterans receiving basal-bolus insulin
    Hopton, Olivia M.
    Waterbury, Nancee, V
    Egge, Jason A.
    Lund, Brian C.
    PHARMACOTHERAPY, 2022, 42 (01): : 45 - 52
12345